DCP Director Philip E. Castle, Ph.D., M.P.H.
The Division of Cancer Prevention furthers the mission of the National Cancer Institute by leading, supporting, and promoting rigorous, innovative research and training to prevent cancer and its consequences to improve the health of all people.
In The News
‘The complexities are staggering.’ U.S. plans huge trial of blood tests for multiple cancers
Science Magazine
June 22, 2022
Applying a pandemic-like response to cancer prevention
STAT First Opinion
August 9, 2021
A Message from the NCI Division of Cancer Prevention Director, Philip E. Castle, Ph.D., M.P.H.
NCI DCP News Note
September 11, 2020
Blog Posts
Screening for Many Cancers with One Test: Uncertainty Abounds
NCI Cancer Currents Blog
April 21, 2022
Advancing Cancer Prevention: A Conversation with NCI’s Dr. Philip Castle
NCI Cancer Currents Blog
July 20, 2021
Ending Cancer as We Know It Is the Work of Many Capable Hands: A Moment to Say "Thank You"
Cancer Prevention Science Blog
December 20, 2021
A Message from the Director: A Year of Making the Cancer Prevention Intention Clear
Cancer Prevention Science Blog
September 20, 2021
Standing on the Shoulders of Giants: Honoring the Scientists who Shaped Cancer Prevention Research During the Last 50 Years
Cancer Prevention Science Blog
March 1, 2021
Scientific Achievements During 2020: An Unforgettable Year of Progress in the NCI Division of Cancer Prevention
Cancer Prevention Science Blog
December 17, 2020
Projects Making Progress in Breast Cancer Detection and Prevention
Cancer Prevention Science Blog
October 19, 2020
Videos/Presentations
National Cancer Advisory Board and NCI Board of Scientific Advisors
NIH VideoCast
Date: June 15, 2022
Runtime: 03:54:58
Joint Meeting of the NCI Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB)
NIH VideoCast
Date: December 9, 2021
Runtime: 04:03:00
NCI's Division of Cancer Prevention; Vision (PDF, 1.46 MB)
December 9, 2021
National Cancer Advisory Board (NCAB) Virtual Subcommittee Meetings (Day 2)
NIH VideoCast
Date: September 2, 2020
Runtime: 02:20:24
Impact of the SARS-CoV-2 Pandemic on the Conduct of DCP Trials: Update on TMIST – Tomosynthesis Mammographic Imaging Screening Trial (DOC, 1.77 MB)
September 2, 2020